MedPath

Effects of Progressive Resistance Training Vasomotor Symptoms in Post Menopausal Women

Not Applicable
Recruiting
Conditions
Post Menopausal
Interventions
Other: Progressive resistance training
Other: Control group
Registration Number
NCT06166264
Lead Sponsor
Riphah International University
Brief Summary

The study will be a randomized clinical trial and will be conducted in Civil Hospital and Kalsoom Hospital Samundry. This study will be completed in time duration of 10 months after the approval of synopsis. Non probability convenience sampling with Randomization technique will be used and 26 participants will be recruited in study after randomization. The subjects will be divided into two groups and the group A will receive Progressive training and Health education and group B will receive only Health education. The data will be assessed at the baseline and after 8th week of treatment. After data collection data will be analyzed by using SPSS version 21.

Detailed Description

The significance of this study is that it may improve the postmenopausal symptoms like depression and vasomotor symptoms which includes hot flushes , night sweats etc .in postmenopausal females. The majority of studies examining the vasomotor symptoms affected by symptoms of post menopause have concentrated on the effects of therapies like hormone therapy.To our knowledge, no studies have looked at the connection between vasomotor symptoms,depression and resistance training. Without doing so, it is challenging to understand how Vasomotor symptoms have an impact. This study sought to fill in the knowledge vaccum by examining the resistance training effect on depression , fatigue and vasomotor symptoms.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
64
Inclusion Criteria

Post-menopausal women with age 50 - 60 years Blood pressure less than 160 / 100 More than or equal to 4 moderate-severe vasomotor symptoms including hot flushes, nocturnal sweats, sweating and poor sleep.

Read More
Exclusion Criteria

Chronic metabolic and endocrine diseases Receiving hormone replacement treatment Surgical menopause Cognitive impairment

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Progressive resistance trainingProgressive resistance training-
Control groupControl group-
Primary Outcome Measures
NameTimeMethod
FATIGUE SEVERITY SCALE6th week

The Fatigue Severity Scale (FSS) is a 9-item scale which measures the severity of fatigue and its effect on a person's activities and lifestyle.

Hot Flash related Interference Scale (HFRDIS) for vasomotor symptoms6th week

The HFRDIS is a 10-item scale which measures the degree hot flashes interfere with daily activities; the tenth item measures the degree hot flashes interfere with overall quality of life. The HFRDIS was internally consistent, with alphas of 0.96 at times

DASS-21( Depression, Anxiety and stress scale 21-item6th Week

DASS-21 is a self reported questionnaire which is used to assess the severity of range of symptoms like depression, anxiety and stress. It is not only used to measure the severity of symptoms but can also be used to assess the subject's response to treatment.The reliability of DASS-21 showed that it has excellent Cronbach's alpha values of 0.81,0.89 and 0.78 for the subscales of depressive, anxiety and stress respectively.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Civil Hospital Samundry

🇵🇰

Samundry, Pakistan

© Copyright 2025. All Rights Reserved by MedPath